Patents Represented by Attorney, Agent or Law Firm Elia J. Lambiris, Esq.
  • Patent number: 6174856
    Abstract: An aqueous insulin composition with improved chemical and physical stability comprising human insulin or an analogue or derivative thereof, a buffer selected from glycylglycine, citrate or TRIS, in particular glycylglycine, and metal ions, in particular calcium or magnesium ions.
    Type: Grant
    Filed: January 7, 1999
    Date of Patent: January 16, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Peter Langballe, Elsebeth Norup